| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
• Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) stock surged 104.67% to $8.33 during Tuesday's pre-market session.
• Owens & Minor, Inc. (NYSE:OMI) stock rose 17.48% to $9.88. The most recent rating by CFRA, on Mar 30, is at Buy, with a price target of $9.
• Tiziana Life Sciences, Inc. (NASDAQ:TLSA) shares increased by 12.90% to $2.10.
• InflaRx, Inc. (NASDAQ:IFRX) shares increased by 10.48% to $3.90.
• Adamis Pharmaceuticals, Inc. (NASDAQ:ADMP) shares moved upwards by 8.19% to $0.40.
• Tilray, Inc. (NASDAQ:TLRY) stock rose 4.99% to $6.94. The most recent rating by Cantor Fitzgerald, on Mar 16, is at Neutral, with a price target of $5.
• Teva Pharmaceutical Indus, Inc. (NYSE:TEVA) shares surged 3.87% to $8.85. The most recent rating by B of A Securities, on Mar 23, is at Underperform, with a price target of $7.
• Amarin Corp, Inc. (NASDAQ:AMRN) stock plummeted 70.99% to $3.94 during Tuesday's pre-market session. The most recent rating by Goldman Sachs, on Mar 31, is at Neutral, with a price target of $4.
• Titan Medical, Inc. (NASDAQ:TMDI) stock declined 30.23% to $0.24.
• Second Sight Medical, Inc. (NASDAQ:EYES) shares declined 21.93% to $0.89.
• Plus Therapeutics, Inc. (NASDAQ:PSTV) stock decreased by 13.22% to $1.97.
• electroCore, Inc. (NASDAQ:ECOR) stock plummeted 9.92% to $1.09. The most recent rating by H.C. Wainwright, on Mar 24, is at Buy, with a price target of $2.
• CHF Solutions, Inc. (NASDAQ:CHFS) stock fell 6.86% to $0.41.
• Cronos Group, Inc. (NASDAQ:CRON) shares decreased by 4.26% to $6.07. According to the most recent rating by Canaccord Genuity, on Mar 31, the current rating is at Sell.
• T2 Biosystems, Inc. (NASDAQ:TTOO) stock decreased by 3.33% to $0.58.
• Grifols, Inc. (NASDAQ:GRFS) stock decreased by 3.25% to $19.93.
• Correvio Pharma, Inc. (NASDAQ:CORV) stock declined 3.25% to $0.36.
Posted In: ADMP AMRN CHFS CORV CRON ECOR EYEG EYES GRFS IFRX OMI PSTV TEVA TLRY TLSA TMDI TTOO
